HeyJaredCarissa Wong
- Indexed articles, last 90 days
- 24
- Latest publication
- Sep 30, 2026
- Outlet visibility, for New Scientist
- Top 50K sites
- Earliest in this view
- Jul 8, 2026
Latest articles
'Astonishing' weight loss when GLP-1 drug used with second medication | New Scientist (opens the original)
Read excerpt
The most potent of the drugs currently approved for inducing weight loss has an even stronger effect when combined with another hormone-targeting treatment. The findings suggest that combining the two could lead to more potent weight-loss therapies, an approach that could become available for wider use in the next few years. “It’s a pretty astonishing degree of weight loss,” says David Preiss at the University of Oxford, who wasn’t involved in the latest research. Tirzepatide, sold under the bra
Don't miss this tragic story of a family with a rare form of dementia | New Scientist (opens the original)
Read excerpt
The Vanishing FamilyRobert KolkerDoubleday (US), 29 September; Quercus (UK), 8 October By the time Barb got the letter with her test results, she had already seen her mother and five of her nine siblings gradually “disappear”. From their forties, they had started to act in unusual ways: they had ignored their children, become unrecognisable to their spouses and lost all sense of social norms. It made her very nervous about her own fate. She knew she had a 50 per cent chance of inheriting the sam
Severe meningitis outbreak caused by bacteria that took genes from microbiome | New Scientist (opens the original)
Read excerpt
A severe outbreak of invasive meningococcal disease, which can cause meningitis and sepsis, in Kent in the UK earlier this year was driven by a bacterial strain that took genes from harmless microbes. This helped the resulting bacteria evade the immune system and obtain iron from blood, boosting their growth. “What was really unusual about the outbreak is quite how explosive it was,” says Emma Wall at Queen Mary University of London, who wasn’t involved in the discovery. “[The bacterium] clearly
Human organoids restore cognition in mice with half a brain | New Scientist (opens the original)
Read excerpt
Human brain organoids have been implanted into mice that are missing half their brain. Tiny versions of the human cerebral cortex – a region involved in memory, movement and thinking – were put into mice that lacked this major brain region. Not only did the organoids integrate into the mice’s brains, but they also restored most of their cognition. “The mouse is [relatively] sick without a cortex, then you transplant these organoids in, and it behaves more like the normal mouse,” says Gabriel Bal
LSD could be approved for anxiety in the US in 2027 | New Scientist (opens the original)
Read excerpt
LSD could be approved for treating anxiety in the US as soon as 2027. This expectation comes after a landmark trial showed that a single dose of the psychedelic drug eased the mental health condition without severe or lasting side effects. “It’s a milestone,” says Greg Cooper at University College London, who wasn’t involved in the trial. “It looks fairly likely that approval from the [US Food and Drug Administration] will happen in the next year or two,” he says. “That would set a precedent for
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For New Scientist, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.